Self-reported hepatitis C virus antibody status and risk behavior in young injectors.

@article{Hagan2006SelfreportedHC,
  title={Self-reported hepatitis C virus antibody status and risk behavior in young injectors.},
  author={Holly Hagan and Jennifer V. Campbell and H. -M. Thiede and Steffanie Anne Strathdee and Lawrence J. Ouellet and Farzana Kapadia and Sharon M. Hudson and Richard S. Garfein},
  journal={Public health reports},
  year={2006},
  volume={121 6},
  pages={710-9}
}
OBJECTIVE This study was conducted to assess the accuracy of self-reported hepatitis C virus (HCV) antibody (anti-HCV) serostatus in injection drug users (IDUs), and examine whether self-reported anti-HCV serostatus was associated with recent injection risk behavior. METHODS In five U.S. cities (Baltimore, Chicago, Los Angeles, New York, and Seattle), 3,004 IDUs from 15 to 30 years old were recruited for a baseline interview to determine eligibility for a randomized controlled trial of a… CONTINUE READING